DE69635304D1 - Faenger fuer oxidantien - Google Patents
Faenger fuer oxidantienInfo
- Publication number
- DE69635304D1 DE69635304D1 DE69635304T DE69635304T DE69635304D1 DE 69635304 D1 DE69635304 D1 DE 69635304D1 DE 69635304 T DE69635304 T DE 69635304T DE 69635304 T DE69635304 T DE 69635304T DE 69635304 D1 DE69635304 D1 DE 69635304D1
- Authority
- DE
- Germany
- Prior art keywords
- oxidants
- faenger
- relates
- modulating
- processes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000007800 oxidant agent Substances 0.000 title abstract 3
- 208000037273 Pathologic Processes Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000009054 pathological process Effects 0.000 abstract 1
- 230000035790 physiological processes and functions Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/545—Heterocyclic compounds
- A61K47/546—Porphyrines; Porphyrine with an expanded ring system, e.g. texaphyrine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nanotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US476866 | 1995-06-07 | ||
US08/476,866 US5994339A (en) | 1993-10-15 | 1995-06-07 | Oxidant scavengers |
US61341896A | 1996-03-11 | 1996-03-11 | |
US613418 | 1996-03-11 | ||
PCT/US1996/010497 WO1996040223A1 (en) | 1995-06-07 | 1996-06-07 | Oxidant scavengers |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69635304D1 true DE69635304D1 (de) | 2006-03-02 |
DE69635304T2 DE69635304T2 (de) | 2006-07-20 |
Family
ID=27045322
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69635304T Expired - Lifetime DE69635304T2 (de) | 1995-06-07 | 1996-06-07 | Faenger fuer oxidantien |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0831891B1 (de) |
JP (1) | JPH11509180A (de) |
AT (1) | ATE306936T1 (de) |
AU (1) | AU725602B2 (de) |
CA (1) | CA2223407C (de) |
DE (1) | DE69635304T2 (de) |
ES (1) | ES2249784T3 (de) |
IL (1) | IL122451A0 (de) |
WO (1) | WO1996040223A1 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6127356A (en) | 1993-10-15 | 2000-10-03 | Duke University | Oxidant scavengers |
US5834457A (en) * | 1996-01-26 | 1998-11-10 | The Regents Of The University Of California | Method of modulating radical formation by mutant cuznsod enzymes |
AU737650B2 (en) | 1997-11-03 | 2001-08-23 | Duke University | Substituted porphyrins |
DE69928655T2 (de) | 1998-04-24 | 2006-08-24 | Duke University | Substituierte porphyrine |
WO2000009111A2 (en) * | 1998-08-11 | 2000-02-24 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Inhibitors of amyloid formation |
WO2000012512A1 (en) | 1998-08-28 | 2000-03-09 | Destiny Pharma Limited | Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them |
DK1155019T3 (da) * | 1999-01-25 | 2006-04-18 | Nat Jewish Med & Res Center | Substituerede porphyriner og deres terapeutiske anvendelse |
US6403788B1 (en) | 2000-07-11 | 2002-06-11 | Eukarion, Inc. | Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species |
EP1439842A4 (de) | 2001-06-01 | 2009-09-02 | Nat Jewish Med & Res Center | Oxidantienfänger zur behandlung von diabetes oder zur verwendung bei der transplantation oder induktion von immuntoleranz |
EP1513537A4 (de) | 2002-06-07 | 2006-09-06 | Univ Duke | Substituierte porphyrine |
ITFI20020200A1 (it) * | 2002-10-21 | 2004-04-22 | Molteni & C Dei Flii Alitti S P A Societa L | Porfirine meso-sostituite. |
EP1692187B1 (de) * | 2003-10-31 | 2012-06-27 | Tae-Yoon Kim | EC SOD und zelltransduzierende EC SOD und Verwendung davon |
US8318803B2 (en) | 2003-10-31 | 2012-11-27 | Tae-Yoon Kim | EC SOD and use thereof |
MXPA06011244A (es) * | 2004-03-29 | 2007-04-13 | Inotek Pharmaceuticals Corp | Compuestos de porfirina sustituida por piridilo, y metodos de uso de los mismos. |
JP2009510083A (ja) | 2005-09-28 | 2009-03-12 | イノテック ファーマシューティカルズ コーポレイション | N−ベンジル置換ピリジルポルフィリン化合物およびその使用方法 |
WO2008114017A2 (en) * | 2007-03-19 | 2008-09-25 | Imperial Innovations Limited | Compositions and methods relating to influenza infection |
KR20140001257A (ko) | 2008-05-13 | 2014-01-06 | 유니버시티 오브 캔사스 | 금속 추출 펩타이드(map) 태그 및 관련된 방법 |
US11382895B2 (en) | 2008-05-23 | 2022-07-12 | National Jewish Health | Methods for treating injury associated with exposure to an alkylating species |
JP6182775B2 (ja) * | 2011-09-21 | 2017-08-23 | 国立大学法人 岡山大学 | 金属ポルフィリン錯体、その製造方法及びそれからなる二酸化炭素固定化触媒、並びに、環状炭酸エステルの製造方法 |
CN102584836B (zh) * | 2011-12-31 | 2014-04-16 | 中国科学院化学研究所 | 一种卟啉笼状化合物及其制备方法与应用 |
US9187735B2 (en) | 2012-06-01 | 2015-11-17 | University Of Kansas | Metal abstraction peptide with superoxide dismutase activity |
US8883857B2 (en) | 2012-12-07 | 2014-11-11 | Baylor College Of Medicine | Small molecule xanthine oxidase inhibitors and methods of use |
JP6444211B2 (ja) * | 2015-02-24 | 2018-12-26 | 学校法人同志社 | ポルフィリン誘導体、及びこれを含む光増感剤等 |
CN105399750B (zh) * | 2015-12-11 | 2018-07-17 | 西北师范大学 | 四氮唑卟啉金属配合物及其合成和作为染料敏化剂的应用 |
CN112694887B (zh) * | 2020-12-07 | 2024-04-26 | 黑龙江省农业科学院植物保护研究所 | 一种发光型传感器及其构筑方法与在检测植物水杨酸含量中的应用 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3464252D1 (en) * | 1983-06-03 | 1987-07-23 | Hoffmann La Roche | Labelled molecules for fluorescence immunoassays and processes and intermediates for their preparation |
GB8429845D0 (en) * | 1984-11-26 | 1985-01-03 | Efamol Ltd | Porphyrins & cancer treatment |
US5248603A (en) * | 1985-09-03 | 1993-09-28 | Symbicom Aktiebolag | Superoxide dismutase |
US4746735A (en) * | 1986-11-21 | 1988-05-24 | The Dow Chemical Company | Regiospecific aryl nitration of meso-substituted tetraarylporphyrins |
US4892941A (en) * | 1987-04-17 | 1990-01-09 | Dolphin David H | Porphyrins |
US5051337A (en) * | 1987-06-10 | 1991-09-24 | Director-General Of Agency Of Industrial Science And Technology | Optical recording material |
GB8805849D0 (en) * | 1988-03-11 | 1988-04-13 | Efamol Holdings | Porphyrins & cancer treatment |
DE3809671A1 (de) * | 1988-03-18 | 1989-09-28 | Schering Ag | Porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
FR2632187B1 (fr) * | 1988-06-02 | 1990-09-14 | Centre Nat Rech Scient | Derives de metalloporphyrines, leur preparation, leur application en therapeutique et leur utilisation pour la preparation de molecules hybrides |
US5171680A (en) * | 1988-06-14 | 1992-12-15 | Chiron Corporation | Superoxide dismutase analogs having novel binding properties |
DK455789D0 (da) * | 1989-09-15 | 1989-09-15 | Symbicom Ab | Polypeptid |
US5236915A (en) * | 1990-05-31 | 1993-08-17 | Health Research, Inc. | Meso poly(4-sulfonatophenyl) porphines as MRI image enhancing agents |
FR2676738B1 (fr) * | 1991-05-22 | 1995-05-05 | Ir2M | Nouveau derive organique de metal de transition a structure porphyrinique, composition therapeutique le contenant, en particulier a activite hypoglycemiante. |
US5262532A (en) * | 1991-07-22 | 1993-11-16 | E.R. Squibb & Sons, Inc. | Paramagnetic metalloporphyrins as contrast agents for magnetic resonance imaging |
US5747026A (en) * | 1993-10-15 | 1998-05-05 | University Of Alabama At Birmingham Research Foundation | Antioxidants |
-
1996
- 1996-06-07 WO PCT/US1996/010497 patent/WO1996040223A1/en active IP Right Grant
- 1996-06-07 AT AT96923328T patent/ATE306936T1/de active
- 1996-06-07 AU AU63870/96A patent/AU725602B2/en not_active Expired
- 1996-06-07 ES ES96923328T patent/ES2249784T3/es not_active Expired - Lifetime
- 1996-06-07 IL IL12245196A patent/IL122451A0/xx unknown
- 1996-06-07 DE DE69635304T patent/DE69635304T2/de not_active Expired - Lifetime
- 1996-06-07 CA CA2223407A patent/CA2223407C/en not_active Expired - Lifetime
- 1996-06-07 JP JP9502304A patent/JPH11509180A/ja active Pending
- 1996-06-07 EP EP96923328A patent/EP0831891B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0831891B1 (de) | 2005-10-19 |
AU725602B2 (en) | 2000-10-12 |
WO1996040223A1 (en) | 1996-12-19 |
EP0831891A4 (de) | 1999-02-03 |
JPH11509180A (ja) | 1999-08-17 |
CA2223407C (en) | 2011-02-08 |
IL122451A0 (en) | 1998-06-15 |
EP0831891A1 (de) | 1998-04-01 |
AU6387096A (en) | 1996-12-30 |
CA2223407A1 (en) | 1996-12-19 |
ATE306936T1 (de) | 2005-11-15 |
DE69635304T2 (de) | 2006-07-20 |
ES2249784T3 (es) | 2006-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69635304D1 (de) | Faenger fuer oxidantien | |
DE69434313D1 (de) | Superoxiddismutase memetika | |
ATE238307T1 (de) | Substituierte porphyrinen | |
DE69928655D1 (de) | Substituierte porphyrine | |
MXPA01007451A (es) | Porfirinas sustituidas. | |
NO2015027I1 (no) | Mepolizumab | |
MY129189A (en) | Prostaglandin agonists and their use to treat bone disorders | |
BG104247A (en) | Resorcinol derivatives | |
GB9514451D0 (en) | Sustained-release formulation | |
BG104780A (en) | Inhibitors of phospholipase enzymes | |
AU5624699A (en) | Use of 5ht-6 antagonists | |
MX9700557A (es) | Dihidrobenzofuranos. | |
PT865294E (pt) | Processo para a reducao ou a manutencao de niveis reduzidos de lipidos no sangue utilizando composicoes de proteina ob | |
ATE510552T1 (de) | Verfahren zur herstellung von sekretierte verkurzte varianten des humanen thyrotropinrezeptors | |
HK1028568A1 (en) | Alpha-ketoamide multicatalytic protease inhibitors | |
ID22718A (id) | Senyawa-senyawa tetrahidropirido | |
ATE305517T1 (de) | Neurotrypsin | |
BG104292A (en) | Methods and compositions for the treatment of rheumatoid arthritis | |
ATE215084T1 (de) | Imidazopyridin-azolidinone | |
DE59506532D1 (de) | Lutschbonbon mit zahnbelags-neutralisierender wirkung | |
ZA949564B (en) | Method for treating constipation using dimeticone. | |
ZA983231B (en) | Substituted benzyloxyimino compounds. | |
DE69924385D1 (de) | Verwendung von angiotensin zur behandlung von krebsmetastasierung | |
ES2122912A1 (es) | Inhibidores de metalocarboxipeptidasas y moleculas derivadas como agentes antitumorales. | |
PE61999A1 (es) | Compuestos de tetrahidropiridina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |